Sanuwave announces intent to acquire Celularity's UltraMist - MassDevice

SNWV) announced that it entered into an exclusive agreement to acquire Celularity’s UltraMist ultrasound healing therapy platform.

The non-binding letter of intent includes the acquisition of UltraMist and exclusive partnership rights for Celularity’s wound care biologic products, according to a news release. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, infectious disease and degenerative disease. Along with the products, 25 wound care professionals are set to join Sanuwave from Celularity.

Suwanee, Ga.-based Sanuwave expects the transaction to close next month and will provide funding for the acquisition with funded term debt and equity. Existing Sanuwave shareholders, directors and officers have committed over $5 million at 25¢ per share to assist.

Sanuwave engaged William Blair for investment banking services to arrange, negotiate and assist in the placement of debt capital for the transaction. William Blair is in advanced discussions with lenders for the debt capital.
“UltraMist and the Celularity wound care biologic products, Biovance and Interyl, are excellent complements to our DermaPace system,” Sanuwave CEO Kevin Richardson said in the release. “The contemplated acquisition would bolster our advanced wound care portfolio and support our growth strategy to offer comprehensive advanced wound care solutions to improve clinical outcomes across the care pathway. The UltraMist device is already established in over 900 wound care clinics and Sanuwave will leverage its sales team to accelerate the penetration of DermaPace into those facilities.”

RSS From Medical Design & Outsourcing

  • Manufacturing group funds $6m in projects to fight COVID-19 in Canada
    Next Generation Manufacturing Canada (NGen), the industry-led organization behind Canada’s advanced manufacturing supercluster, has announced an additional $6 million in funding for projects dedicated to fighting the COVID-19 pandemic in Canada. To date, NGen has supported a total of 19 such projects amounting to $27 million. Three companies are the latest recipients of cash from… […]
  • Medline commits $1m to organizations advancing social justice for Black Americans
    Medline Industries recently announced that will donate $1 million to four organizations working to advance diversity, inclusion and equality for Black Americans. The organizations are the Black Lives Matter, the NAACP, the National Urban League and the United Negro College Fund. The Northfield, Ill.-based company said it chose the recipients based on their missions to… […]
  • Wyss Institute lands $16m to repurpose drugs for COVID-19
    Lindsay Brownell, Wyss Institute The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded Harvard university’s Wyss Institute for Biologically Inspired Engineering $16 million to identify and test FDA-approved drugs that could be repurposed to prevent or treat COVID-19. Using its computational drug discovery pipelines and human Organ Chip technologies, the institute has already found… […]
  • FDA extends switch to virtual meetings, warns it may miss some deadlines
    The FDA said Monday that it will continue holding formal meetings with device sponsors virtually due to the COVID-19 pandemic for now. The agency also said that it may miss some deadlines in completing user-fee work on premarket device approval applications. In a Q&A document, the agency said that until further notice, all requests for… […]
  • XaTek to develop rugged ClotChip for U.S. Navy
    XaTek today announced a deal with the U.S. Navy to develop its ClotChip handheld blood coagulation reader for military deployment. The reader measures a patient’s bleeding risk from one drop of blood from a fingerstick. It will be adapted to withstand excessive impact and vibration of trauma patient support. The adaptions will be validated in… […]
  • DOD launches $100m initiative to return COVID-19-related medtech, pharma manufacturing to the U.S.
    The U.S. Department of Defense announced today that it will dedicate $100 million ized by the CARES Act to boost medtech and pharmaceutical manufacturing in the U.S. Working with DOD, the U.S. International Development Finance Corporation (DFC) launched a request for proposals from companies seeking financing under the Defense Production Act, which prioritizes government orders… […]
  • Hahn says FDA will keep some COVID-19-era changes in place
    The head of the FDA says some changes the agency made during the height of the COVID-19 pandemic will become permanent. Dr. Stephen Hahn told members of the Medical Device Innovation Consortium (MDIC) on June 19 that the agency will rely even more on real-world evidence regarding the performance of approved or cleared devices and… […]
  • DeviceTalks Weekly: Stryker CEO Kevin Lobo says medtech can increase workforce diversity
    This week’s DeviceTalks Weekly podcast episode talks with industry leaders about improving worker diversity and developing new ways to treat COVID-19 patients. Kevin Lobo, chairman and CEO of Stryker, explains how his company — and the industry group AdvaMed — has been working  to increase diversity of its workforce, particularly in senior and sales positions.… […]
  • COVID-19 lessons learned: 2 manufacturers, a healthcare system and a logistics company share their wisdom
    The COVID-19 pandemic put medtech contract manufacturers, OEMs, distributors and healthcare providers in situations for which they were unprepared, particularly with their supply chains. What they learned will undoubtedly help them all going forward, especially if the world faces a second wave or another novel virus. Here are some supply chain lessons learned by Nonin… […]
  • Assisted living survey shows ongoing struggle for supplies during COVID-19 pandemic
    A survey of National Center for Assisted Living members revealed that a number of people are still facing equipment shortages during the COVID-19 pandemic. Assisted living facilities have been hit particularly hard by the virus, with a recent report from the Associated Press citing government data confirming that nursing 真人百家家乐app下载home residents account for nearly 1 in 10… […]
  • Medtronic, Foxconn aim to make 10,000 ventilators
    Medtronic (NYSE:MDT) and Foxconn said today they will boost ventilator production to 10,000 over the next year at Foxconn’s Wisconsin plant. The companies announced in April that Foxconn would begin production of Medtronic’s Puritan Bennett 560 ventilators at the plant in Mount Pleasant, Wis., with a goal of 400 ventilators per week by the end of… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.